PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
For the period ended Dec 31, 2024. Filed Mar 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 17, 2025
PACB$2.24-5.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
| Years Ended December 31, | |||
|---|---|---|---|
| (in thousands, except per share amounts) | 2024 | 2023 | 2022 |
| Revenue: | |||
| Product revenue | $136,149 | $183,872 | $108,699 |
| Service and other revenue | 17,865 | 16,649 | 19,605 |
| Total revenue | 154,014 | 200,521 | 128,304 |
| Cost of Revenue: | |||
| Cost of product revenue | 92,284 | 127,568 | 60,932 |
| Cost of service and other revenue | 14,057 | 14,754 | 13,899 |
| Amortization of acquired intangible assets | 9,393 | 1,983 | 733 |
| Loss on purchase commitment | 998 | 3,436 | 3,705 |
| Total cost of revenue | 116,732 | 147,741 | 79,269 |
| Gross profit | 37,282 | 52,780 | 49,035 |
| Operating Expense: | |||
| Research and development | 134,922 | 187,170 | 193,000 |
| Sales, general and administrative | 175,017 | 169,818 | 160,854 |
| Impairment charges | 184,500 | — | — |
| Merger-related expenses | — | 9,042 | — |
| Change in fair value of contingent consideration | (850) | 15,060 | 2,377 |
| Amortization of acquired intangible assets | 18,006 | 6,157 | — |
| Total operating expense | 511,595 | 387,247 | 356,231 |
| Operating loss | (474,313) | (334,467) | (307,196) |
| Loss on extinguishment of debt | — | (2,033) | — |
| Gain on debt restructuring | 154,407 | — | — |
| Interest expense | (13,412) | (14,343) | (14,690) |
| Other income, net | 23,783 | 32,684 | 7,638 |
| Loss before income taxes | (309,535) | (318,159) | (314,248) |
| Income tax provision (benefit) | 316 | (11,424) | — |
| Net loss | (309,851) | (306,735) | (314,248) |
| Other comprehensive income (loss): | |||
| Unrealized gain (loss) on investments | 203 | 4,984 | (3,678) |
| Comprehensive loss | $(309,648) | $(301,751) | $(317,926) |
| Net loss per share: | |||
| Basic | $(1.13) | $(1.21) | $(1.40) |
| Diluted | $(1.59) | $(1.21) | $(1.40) |
| Weighted average shares outstanding used in calculating net loss per share | |||
| Basic | 274,488 | 253,629 | 224,550 |
| Diluted | 288,366 | 253,629 | 224,550 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.